Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact
In a recent study posted to medRxiv preprint* server, researchers at pharmaceutical and biotechnology company Moderna, Inc. estimated the economic and clinical impact of updated […]
Read more